The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

National Health Investors Inc

NYSE: NHI
Last

(U.S.) $56.55

Today's change-0.07 -0.12%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.
 

National Health Investors Inc

NYSE: NHI
Last

(U.S.) $56.55

Today's change-0.07 -0.12%
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

National Health Investors Inc down (U.S.)$0.07

National Health Investors Inc closed lower Friday, dropping (U.S.)$0.07 or 0.12% to (U.S.)$56.55. Over the last five days, shares have lost 8.73% and are down 7.10% for the last year to date. This security has underperformed the S&P 500 by 10.73% during the last year.

Key company metrics

  • Open(U.S.) $57.05
  • Previous close(U.S.) $56.62
  • High(U.S.) $57.46
  • Low(U.S.) $56.07
  • Bid / Ask-- / --
  • YTD % change-7.10%
  • Volume220,291
  • Average volume (10-day)321,901
  • Average volume (1-month)280,767
  • Average volume (3-month)253,049
  • 52-week range(U.S.) $53.64 to (U.S.) $73.32
  • Beta0.67
  • Trailing P/E17.07×
  • P/E 1 year forward17.16×
  • Forward PEG2.68×
  • Indicated annual dividend(U.S.) $3.40
  • Dividend yield6.01%
  • Trailing EPS(U.S.) $3.31
Updated February 12 4:02 PM EST. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+57.21%

Based on its net profit margin of 57.21%, National Health Investors Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX2.43%Sector:HealthcareIndustry:Healthcare Facilities

Latest Company News

  • about 2 years agoA
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q3/2015Q2/2015Q1/2015Q4/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedSep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014
Revenue58565646
Total other revenue--------
Total revenue58565646
Gross profit--------
Total cost of revenue--------
Total operating expense25242617
Selling / general / administrative2342
Research & development--------
Depreciation / amortization13131310
Interest expense (income), net operating10986
Unusual expense (income)00--0
Other operating expenses, total--------
Operating income33323028
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax34323028
Income after tax34323028
Income tax, total------0
Net income34313028
Total adjustments to net income--------
Net income before extra. items34313028
Minority interest000-1
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items34313028
Inc. avail. to common incl. extra. items34313028
Diluted net income34313028
Dilution adjustment0--00
Diluted weighted average shares38383834
Diluted EPS excluding extraordinary itemsvalue per share0.890.830.790.80
Dividends per sharevalue per share0.850.850.850.77
Diluted normalized EPSvalue per share0.890.820.790.80